A Well-Documented Abstract (Archived)

All central registries that report to NPCR require text documentation. Supporting text should be on all coded data items in your abstract for both analytic and non-analytic cases. If information is unavailable, state it in the abstract in the appropriate text data item. Do not simply document NA. Provide a good history of why the cancer is reported and why the patient presented to your facility. All data items must be well documented. The text helps with audits by including the primary site of origin, demographics, seer summary stage, SSDIs, and treatment administered. Your abstract text should tell a story and make sense when auditors review it. Text documentation is an essential component of a complete electronic report and is heavily utilized for quality control, visual QC, and special studies. Text is needed to justify coded values and to document supplemental information not transmitted within coded values. High-quality text documentation facilitates consolidating information from multiple reporting sources at the central registry. 


Text documentation should always include the following components:

  • Include in the patient’s history and the reason for the visit to the facility regardless of class of case and if there is an active disease, history, or the patient is currently undergoing treatment.  

  • The primary site should include text to support the subsite code.  

  • Location includes the facility, physician, and other locations where the event occurred or the patient was diagnosed, including tests, studies, and treatment.  

  • Provide dates (chronological order) and descriptions of events, including tests, studies and treatment administered and types if results were positive or negative


Treatment supporting text:  

  • The surgery text should include all surgical procedures performed, the procedure's name, and if lymph node resection was performed to support what is coded in the scope of regional nodes.  

  • For radiation, include dates, location, site treated, and treatment modality.  

  • For chemo, hormones, immunotherapy includes each agent by name, not just by protocol name.

The SEER summary stage text includes the extent of disease, which may include TNM if available, and the rationale for code. 


Below is a list of FCDS/NAACCR Data Items that require additional information and supporting text documentation:

  • 2520 Text – DX Procedures – Physical Exam 

  • 2530 Text – DX Procedures – X-Ray/Scans  

  •  2540 Text – DX Procedures – Scopes  

  • 2550 Text – DX Procedures – Lab Tests  

  • 2560 Text – DX Procedures – Operative Report  

  • 2570 Text – DX Procedures – Pathology Report  

  • 2580 Text – Primary Site Title 

  • 2590 Text – Histology Title

  •  2600 Text – Staging 

  • 2610 RX Text – Surgery 

  • 2620 RX Text – Radiation (Beam) Phase I Radiation Treatment Modality 

  • 2630 RX Text – Radiation Other 

  • 2640 RX Text – Chemo includes each agent by name, not just by protocol name 

  • 2650 RX Text – Hormone 

  • 2660 RX Text – BRM/immunotherapy 

  • 2670 RX Text – Other  2680 Text – Remarks  

  • 2690 Text – Place of Diagnosis 

  • 310 Usual Occupation 

  • 320 Usual Industry

Please refer to the FCDS Data Acquisition Manual Appendix L for a list of specific core data items that require text documentation and information on NCRA Informational Abstracts, free to download, that provide cancer site-specific information for text in abstracts at https://www.cancerregistryeducation.org/rr The Text Required section includes the set of data items where documentation must be entered to verify complete and accurate coding. Please read the Introduction to Text Documentation, which precedes this section, to become familiar with FCDS text requirements. The text requirements are monitored by FCDS QC Review and through FCDS EDITS. 


Click on the tags below to see related articles:

Previous
Previous

2023 Jean Byers Award for Excellence in Cancer (Archived)

Next
Next

Cancer Reporting Completeness Report: June 30, 2024 (Archived)